BioBridges | Experience That Works

Avatar by Amy Steinberg Published Jan 18, 2019 Last updated Jan 18, 2019

BioBridges has been engaged by an emerging biotechnology company to oversee a series of US- and EU-based oncology studies as they move out of Ph1b and into dose expansion.

Leave a Reply